
Whitehaven Coal Ltd (ASX: WHC) shares have enjoyed sector tailwinds to start 2026.
The Australian coal mining company has seen its share price rise 55% in the last 12 months.
That includes a gain of 17% already in 2026 alone.
Whitehaven Coal develops and operates coal mines in Queensland and New South Wales. The company produces metallurgical and thermal coal. It operates mines, including open-cut and underground, located in the Gunnedah Coal Basin in New South Wales.
It has benefited from a surge in global commodity prices as the Australian energy sector has steamed ahead so far this year.
However after such a rapid rise, investors may be considering selling to cash in profits.
A new report from Ord Minnett has provided updated guidance.
Here is what the wealth and investment services firm had to say.
Commodity tailwinds picking up
In a note out of Ord Minnett yesterday, it said Whitehaven Coal delivered a strong December-quarter result.
This included managed production of 8.7 million tonnes (Mt).
This exceeded Ord Minnett’s expectations by approximately 10%.
Additionally, net debt declined faster than expected to $700 million. This was 6% below estimates.
Ord Minnett said the improving outlook for metallurgical coal provides a significant tailwind, and it forecasts a strong underlying free cash flow (FCF) outlook for CY26 of $590 million for an 8% yield.
This is based on a commodity price forecast of US$210 a tonne for premium low-volatile hard coking coal (PLV-HCC) in CY26.
Price target adjustment
Whitehaven Coal shares closed yesterday at $9.16 after a 3% gain.
Ord Minnett said after incorporating the December-quarter result, its target price increased 4% to $9.90.
From yesterday’s closing price, this indicates a further upside of approximately 8%.
We reaffirm our Accumulate recommendation given the outlook for underlying FCF and shareholder returns, although we note Whitehaven is starting to screen less attractively against smaller peers that have greater metallurgical coal exposure.
What are other experts saying about Whitehaven Coal shares?
Sentiment appears mixed on Whitehaven Coal shares.
Late last month, the team at Bell Potter placed a sell recommendation on the coal miner.
This was along with a price target of $8.40, which is slightly below current levels.
Bell Potter said near-term output from Queensland is expected to be disrupted by heavy rainfall and Cyclone Koji.
The broker also warned metallurgical coal prices could ease from current elevated levels.
Elsewhere, target prices are hovering between $8.40 and $9.90, with the most common rating being a hold.
The post Is there any more upside for Whitehaven Coal shares according to Ord Minnett? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Whitehaven Coal Limited right now?
Before you buy Whitehaven Coal Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Whitehaven Coal Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Here are the top 10 ASX 200 shares today
- Why Imricor, Ioneer, Star, and Whitehaven Coal shares are falling today
- Why it’s time to sell Whitehaven Coal shares – Expert
- Why Appen, Imricor, Sunrise Metals, and Whitehaven Coal shares are charging higher today
- Why is the Whitehaven Coal share price smashing the benchmark on Thursday?
Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.